Abstract |
To determine whether antibodies to the 19-kDa fragment of merozoite surface protein 1 ( MSP1(19)) help to control blood-stage Plasmodium falciparum infection, we performed a rechallenge experiment of previously infected Aotus monkeys. Monkeys previously exposed to the FVO strain of P. falciparum that did or did not develop high antibody titers to MSP1(19) and malaria-naïve monkeys were challenged with erythrocytes infected with the same strain. Prepatent periods were prolonged in previously infected monkeys compared with malaria-naïve monkeys. Previously infected monkeys with preexisting anti-MSP1(19) antibodies showed low peak parasitemias that cleared spontaneously. Previously infected monkeys that had no or low levels of pre-existing anti-MSP1(19) antibodies also showed low peak parasitemias, but because of low hematocrits, all of these animals required treatment with mefloquine. All previously malaria-naïve animals were treated because of high parasitemias. The results of this study suggest that antibody to the 19-kDa carboxy-terminal fragment of MSP1 plays a role in preventing the development of anemia, an important complication often associated with malaria.
|
Authors | Alfonso S Gozalo, Carmen M Lucas, Jing Qin, B Ted Hall, Alan J Magill |
Journal | Comparative medicine
(Comp Med)
Vol. 57
Issue 4
Pg. 396-401
(Aug 2007)
ISSN: 1532-0820 [Print] United States |
PMID | 17803055
(Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Antibodies, Protozoan
- Antimalarials
- Merozoite Surface Protein 1
- Mefloquine
|
Topics |
- Anemia
(immunology, parasitology, pathology)
- Animals
- Antibodies, Protozoan
(blood, immunology)
- Antimalarials
(therapeutic use)
- Aotidae
- Disease Models, Animal
- Erythrocytes
(parasitology)
- Malaria, Falciparum
(complications, immunology, pathology)
- Mefloquine
(therapeutic use)
- Merozoite Surface Protein 1
(administration & dosage, immunology)
- Monkey Diseases
(immunology, parasitology, pathology)
- Parasitemia
(drug therapy, immunology)
- Plasmodium falciparum
(growth & development, immunology)
|